1.38

3.50% -0.05

After Hours: 1.37 -0.010 -0.72%

Actinium Pharmaceuticals Inc (ATNM)

Overview News Price History Option Chain Discussions Forecast Stock Split

Actinium Pharmaceuticals Inc stock is traded at $1.38, with a volume of 304.46K. It is down -3.50% in the last 24 hours and down -12.66% over the past month. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for patients with cancers lacking effective treatment options. Its lead product candidate is Iomab-B that is in Phase III clinical studies for myeloablation and conditioning of the bone marrow prior to a bone marrow transplant for patients with relapsed or refractory acute myeloid leukemia (AML) age 55 and older. The company is also developing Actimab-A, which is in Phase II clinical trials for the treatment of patients newly diagnosed with AML over the age of 60, as well as in Phase I clinical trials in combination with CLAG-M for patients with relapsed or refractory AML; and Actimab-M that is in Phase I clinical trials for patients with refractory multiple myeloma. Actinium Pharmaceutical, Inc. was founded in 2000 and is based in New York, New York.

Previous Close:

$1.43

Open:

$1.41

24h Volume:

304.46K

Relative Volume:

1.67

Market Cap:

$43.05M

Revenue:

$81,000

Net Income/Loss:

$-41.04M

P/E Ratio:

-1.0479

EPS:

-1.3169

Net Cash Flow:

$-30.69M

1W Performance:

-9.80%

1M Performance:

-12.66%

6M Performance:

-10.97%

1Y Performance:

-19.30%

1-Day Range:

$1.36

$1.43

1-Week Range:

$1.36

$1.5535

52-Week Range:

$1.06

$2.41

Actinium Pharmaceuticals Inc Stock (ATNM) Company Profile

Name

Actinium Pharmaceuticals Inc

Sector

Healthcare (1136)

Industry

Biotechnology (633)

Phone

646-767-3870

Address

275 Madison Avenue, 7th Floor, New York, NY

Employee

Twitter

@actiniumpharma

Next Earnings Date

2025-08-08

Latest SEC Filings

ATNM's Discussions on Twitter

Compare ATNM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATNM Actinium Pharmaceuticals Inc	1.38	44.61M	81,000	-41.04M	-30.69M	-1.3169
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Actinium Pharmaceuticals Inc Stock (ATNM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-07-24	Downgrade	B. Riley Securities	Buy → Neutral
May-14-24	Initiated	Stephens	Overweight
Sep-06-23	Initiated	HSBC Securities	Buy
Feb-21-23	Downgrade	William Blair	Outperform → Mkt Perform
Sep-08-22	Initiated	Cantor Fitzgerald	Overweight
Aug-25-22	Initiated	B. Riley Securities	Buy
Nov-05-20	Initiated	Alliance Global Partners	Buy
Dec-06-17	Initiated	B. Riley FBR, Inc.	Buy
Oct-23-17	Resumed	ROTH Capital	Buy
Sep-14-17	Initiated	Maxim Group	Buy
Aug-25-16	Initiated	ROTH Capital	Buy
Feb-29-16	Initiated	H.C. Wainwright	Buy
Oct-15-15	Initiated	FBR Capital	Outperform
Oct-01-14	Initiated	MLV & Co	Buy
Jul-22-14	Initiated	Canaccord Genuity	Buy

View All

Actinium Pharmaceuticals Inc Stock (ATNM) Latest News

Nov 03, 2025

How moving averages guide Actinium Pharmaceuticals Inc. tradingWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com

Nov 03, 2025

Identifying reversal signals in Actinium Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com

Nov 03, 2025

What momentum shifts mean for Actinium Pharmaceuticals Inc.July 2025 Opening Moves & Community Consensus Stock Picks - newser.com

Nov 03, 2025

Why retail traders accumulate Actinium Pharmaceuticals Inc. (Delaware) stockDividend Hike & Safe Capital Growth Tips - newser.com

Nov 03, 2025

Is Actinium Pharmaceuticals Inc. stock ready for a breakoutJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com

Nov 03, 2025

Actinium Pharmaceuticals, Inc. to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference - PR Newswire

Nov 03, 2025

Is Actinium Pharmaceuticals Inc. stock a smart buy before Fed meetingProduct Launch & Fast Entry Momentum Alerts - newser.com

Nov 03, 2025

Is Actinium Pharmaceuticals Inc. (7AY1) stock a momentum leaderWeekly Volume Report & Short-Term High Return Strategies - newser.com

Nov 03, 2025

Can you recover from losses in Actinium Pharmaceuticals Inc.July 2025 Opening Moves & AI Optimized Trade Strategies - newser.com

Nov 03, 2025

How Actinium Pharmaceuticals Inc. stock performs in rate cut cycles2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com

Nov 03, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock expands through international markets2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com

Nov 03, 2025

Is Actinium Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com

Nov 03, 2025

How supply shortages influence Actinium Pharmaceuticals Inc. (Delaware) stockTrade Exit Summary & Low Risk High Win Rate Picks - newser.com

Nov 03, 2025

Nov 02, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock stacks up against competitors2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com

Nov 02, 2025

Will Actinium Pharmaceuticals Inc. (7AY1) stock outperform foreign stocksEntry Point & Weekly Breakout Opportunity Watchlist - newser.com

Nov 02, 2025

Has Actinium Pharmaceuticals Inc. found a price floorIndex Update & AI Driven Stock Reports - newser.com

Nov 02, 2025

Nov 01, 2025

Why Actinium Pharmaceuticals Inc. (Delaware) stock stays undervaluedMarket Volume Summary & AI Based Buy and Sell Signals - newser.com

Nov 01, 2025

Oct 31, 2025

How Actinium Pharmaceuticals Inc. (Delaware) stock responds to bond marketJuly 2025 Volume & Fast Moving Market Watchlists - newser.com

Oct 31, 2025

Will Actinium Pharmaceuticals Inc. (7AY1) stock gain from lower interest ratesQuarterly Market Summary & Community Consensus Trade Alerts - newser.com

Oct 31, 2025

Published on: 2025-10-31 04:06:04 - newser.com

Oct 31, 2025

Is Actinium Pharmaceuticals Inc. (Delaware) stock a buy on weaknessWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com

Oct 31, 2025

Oct 30, 2025